Hengrui Liu

8PUBLICATIONS
21CO-AUTHORS
Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesGene and molecular therapyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2025
Selective Small-Molecule Activator of Patient-Derived GPX4 Variant.

Hengrui Liu, Farhad Forouhar, Russell Saneto

|Jan 03, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening.

Hengrui Liu, Arie Zask, Farhad Forouhar

|Oct 27, 2023
APR-246 increases tumor antigenicity independent of p53.

Judith Michels, Divya Venkatesh, Cailian Liu

|Apr 08, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.

Hengrui Liu, Sho Iketani, Arie Zask

|Dec 21, 2021
Characterization of a patient-derived variant of GPX4 for precision therapy.

Hengrui Liu, Farhad Forouhar, Tobias Seibt

|May 06, 2021
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.

Sho Iketani, Farhad Forouhar, Hengrui Liu

Pageof 2

Frequent Collaborators

7 joint publications

Brent R Stockwell

4 joint publications

Sho Iketani

4 joint publications

David D Ho

3 joint publications

Manoj S Nair